HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo

HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo

Abstract Background In this work, we investigated the genetic diversity of HIV-1 and the presence of mutations conferring antiretroviral drug resistance in 50 drug-naïve infected persons in the Republic of Congo (RoC). Samples were obtained before large-scale access to HAART in 2002 and 2004. Method...

Full description

Bibliographic Details
Main Authors: Fabien Roch Niama, Nicole Vidal, Halimatou Diop-Ndiaye, Etienne Nguimbi, Gabriel Ahombo, Philippe Diakabana, Édith Sophie Bayonne Kombo, Pembe Issamou Mayengue, Simon-Charles Kobawila, Henri Joseph Parra, Coumba Toure-Kane
Format: Article
Language:English
Published: BMC 2017-07-01
Series:BMC Research Notes
Subjects:
HIV
Subtypes
Recombination
Drugs resistances
Congo
Online Access:http://link.springer.com/article/10.1186/s13104-017-2550-8

Internet

http://link.springer.com/article/10.1186/s13104-017-2550-8

Similar Items